GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mediera Corp (ROCO:5398) » Definitions » Buyback Yield %

Mediera (ROCO:5398) Buyback Yield % : 0.00 (As of May. 19, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Mediera Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Mediera's current buyback yield was 0.00%.


Mediera Buyback Yield % Historical Data

The historical data trend for Mediera's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mediera Buyback Yield % Chart

Mediera Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mediera Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mediera's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Mediera's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mediera's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mediera's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Mediera's Buyback Yield % falls into.



Mediera Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Mediera's Buyback Yield for the fiscal year that ended in Dec. 2022 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 811.226
=0.00%

Mediera's annualized Buyback Yield for the quarter that ended in Mar. 2024 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0) * 4 / 887.905725
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Mar. 2024) data.


Mediera Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Mediera's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mediera (ROCO:5398) Business Description

Traded in Other Exchanges
N/A
Address
No. 239 Datong Road, Section 1, 16th Floor, Xizhi District, New Taipei, TWN
Mediera Corp is engaged in domestic research and development, production and manufacturing of various power supply components, and launched its own brand. MEDIERA is also committed to the production of customized products and OEM. It has been more active in the transformation and layout of the development of medical biotechnology. For example, medicines, healthy foods, and medical equipment that greatly help human health have become the focus of development in recent years. In addition, combined with the scientific and technological research and development capabilities of the Electronics Division, advanced The application of electronic micro-control patented technology in electronic medical equipment that can help patients improve their quality of life is a major breakthrough for company.

Mediera (ROCO:5398) Headlines

No Headlines